Loading company…
MiRNDa develops biotechnology and in vitro diagnostic products, including blood-based RNA analysis for early cancer detection.
MiRNDa develops biotechnology and in vitro diagnostic products. Its work includes diagnostic medical devices, pharmaceuticals, and blood-based RNA modification analysis technology for early cancer detection and diagnosis. Founded in 2025, the company is based in Tokyo, Japan.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in